NMR-based metabolomics platform for studies worldwide.
Our platform offers scalable, batch-effect free, comprehensive metabolic analysis to accelerate scientific breakthroughs.
Our biomarker panel provides a comprehensive view of an individual’s overall health. This data, or a combination of it with other omics, can be used to discover novel associations between different areas of health, evaluate effects of drug and lifestyle interventions.
The data is batch-effects free and used by large cohorts worldwide, making it highly suitable for validation and replication studies.
Our clinically validated CE-marked biomarkers including ApoA-1, ApoB, routine lipids and glucose help move academic findings to a clinical context, while our additional markers help to further explain the molecular mechanisms associated with chronic diseases.
Nightingale’s biomarkers provide a broad view of the host’s overall health by including clinically established and emerging metabolic markers in numerous pathways.
Our platform enables fast, scalable and affordable analysis even for large sample sets by utilising NMR technology.
Deelen et al., NAT COMMUN 2019;10:3346
Locke et al. Nature 2019; Jul 31
Sliz et al. Circulation. 2018;138:2499–2512
Liu et al. Nat Med. 2020;26;110–117
Whether you have a question or you would like to ask for an offer, let us know and we'll get back to you very soon.